APA (7th ed.) Citation

Stavi, V., Chen, C., Novitzky-Basso, I., Remberger, M., Law, A., Gerbitz, A., . . . Lipton, J. H. (2026). CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM – a single center analysis. Leukemia & Lymphoma, 67(9), 1907. https://doi.org/10.1080/10428194.2026.2668034

Chicago Style (17th ed.) Citation

Stavi, Vered, et al. "CMV Reactivation Post Allogeneic Stem Cell Transplantation Decreases Relapse Risk and Survival, and Increases NRM – a Single Center Analysis." Leukemia & Lymphoma 67, no. 9 (2026): 1907. https://doi.org/10.1080/10428194.2026.2668034.

MLA (9th ed.) Citation

Stavi, Vered, et al. "CMV Reactivation Post Allogeneic Stem Cell Transplantation Decreases Relapse Risk and Survival, and Increases NRM – a Single Center Analysis." Leukemia & Lymphoma, vol. 67, no. 9, 2026, p. 1907, https://doi.org/10.1080/10428194.2026.2668034.